News & Analysis on Clinical Trial Services & Contract Research And Development
PEOPLE ON THE MOVE
National Pharmaceutical Council
By Fiona BARRY
- Last updated on
The National Pharmaceutical Council (NPC) has appointed a senior Merck & Co. VP as its chair for the next year. Patrick Magri has served on NPC's board since 2013.
"Patrick's considerable expertise has been invaluable in our efforts to expand NPC's research and communications while he has served on the Board," said NPC president Dan Leonard. "As we address the changing health care environment, I know his guidance will help us to constructively address ongoing and emerging health policy challenges."
Magri began working for Merck in 1990, and in 2012 became senior vice president overseeing managed markets and policy in the United States.
The NPC Board also elected Joshua Ofman, senior vice president, global value access & policy, Amgen, Inc., as vice chair; Jeffrey Stewart, vice president, US commercial operations, AbbVie, as treasurer; and Richard Bagger, senior vice president, corporate affairs and market access, Celgene Corporation, to serve on the executive committee.